US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eterna Therapeutics Inc.

0.1963

-0.0107-5.17%

Volume:137.15K

Turnover:27.75K

Market Cap:12.21M

PE:-0.06

High:0.2170

Open:0.2030

Low:0.1921

Close:0.2070

Loading ...

Overview Company News Filings

Ernexa Therapeutics Presented Promising Data on Innovative Cell Therapy Treatment at AACR Annual Meeting 2025

Ernexa Therapeutics Announces New Data to be Presented at AACR Annual Meeting 2025

Ernexa Therapeutics Closes New Funding Round

Eterna appoints Zeldis, Sather to scientific advisory board

Eterna Therapeutics Announces Expansion of Scientific Advisory Board

THOMSON REUTERS

Press Release: Eterna Therapeutics Announces Expansion of Scientific Advisory Board

Eterna Therapeutics Reports Positive Preclinical Results for Cancer Therapy ERNA-101; Shares Jump

MT Newswires Live

Eterna announces preclinical study results on ERNA-101

Eterna Therapeutics Inc - Erna-101 Expected to Enhance Efficacy of CAR-T and Car-Nk Therapies

THOMSON REUTERS

Eterna Therapeutics Announces Positive Preclinical Study Results on Lead Product Erna-101 in Ovarian Cancer

THOMSON REUTERS

Eterna Therapeutics Inc - Erna-101 Treated Mice Show Significant Survival Advantage

THOMSON REUTERS

Eterna Therapeutics Announces Positive Preclinical Study Results on Lead Product ERNA-101 in Ovarian Cancer

Eterna Therapeutics Announces Appointment of DR. Elena Ratner to Board of Directors

THOMSON REUTERS

Press Release: Eterna Therapeutics Announces Appointment of Dr. Elena Ratner to Board of Directors

BRIEF-Eterna Therapeutics Inc - Receives Nasdaq Notice For Minimum Bid Price Non-Compliance

Eterna launches research to evaluate ERNA-101

Eterna: to Investigate Ability of Erna-101 to Induce, Modulate Antitumor Immunity in Ovarian Cancer, Breast Cancer Models Through Research

THOMSON REUTERS

Eterna Therapeutics Launches Research to Evaluate its Lead Induced Mesenchymal Stem Cell Therapy Candidate’s (ERNA-101) Ability to Induce and Modulate Antitumor Immunity in Ovarian Cancer and Breast Cancer Models

BRIEF-Eterna Therapeutics Announces Up To $1 Million Stock Repurchase Program

Eterna Therapeutics announces up to $1 million stock repurchase program

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ERNA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ERNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ERNA\",,,,,undefined,":{"symbol":"ERNA","market":"US","secType":"STK","nameCN":"Eterna Therapeutics Inc.","latestPrice":0.1963,"timestamp":1746129600000,"preClose":0.207,"halted":0,"volume":137146,"delay":0,"floatShares":26679000,"shares":62178945,"eps":-3.26482,"marketStatus":"Pre-Mkt","change":-0.0107,"latestTime":"05-02 05:57:46 EDT","open":0.203,"high":0.217,"low":0.1921,"amount":27752.8851319,"amplitude":0.12029,"askPrice":0.2408,"askSize":100,"bidPrice":0.1796,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.26482,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746192600000},"marketStatusCode":1,"adr":0,"listingDate":465451200000,"exchange":"NASDAQ","adjPreClose":0.1963,"postHourTrading":{"tag":"盘后","latestPrice":0.1963,"preClose":0.1963,"latestTime":"19:20 EDT","volume":18,"amount":3.51,"timestamp":1746141607243},"volumeRatio":0.6122064538691788},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ERNA\",,,,,undefined,":{"symbol":"ERNA","floatShares":26679000,"roa":"-39.64%","roe":"-2264.31%","lyrEps":-3.26482,"volumeRatio":0.6122064538691788,"shares":62178945,"dividePrice":0,"high":0.217,"amplitude":0.12029,"preClose":0.207,"low":0.1921,"week52Low":0.150601,"pbRate":"7.18","psRate":"20.97","week52High":2.625,"institutionHeld":-0.0129,"latestPrice":0.1963,"eps":-3.26482,"divideRate":0,"volume":137146,"delay":0,"ttmEps":-3.26482,"open":0.203,"prevYearClose":0.294,"prevWeekClose":0.216,"prevMonthClose":0.207,"prevQuarterClose":0.178,"fiveDayClose":0.2049,"twentyDayClose":0.191,"sixtyDayClose":0.3589},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ERNA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531533147","title":"Ernexa Therapeutics Presented Promising Data on Innovative Cell Therapy Treatment at AACR Annual Meeting 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2531533147","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531533147?lang=en_us&edition=fundamental","pubTime":"2025-04-29 20:30","pubTimestamp":1745929800,"startTime":"0","endTime":"0","summary":"Study showed engineered stem cell-derived therapy recruits key immune cells and slows tumor growth, supporting continued development of Ernexa’s advanced cancer pipeline. CAMBRIDGE, Mass., April 29, 2025  -- Ernexa Therapeutics , developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, presented noteworthy new data at the American Association for Cancer Research  Annual Meeting 2025 in Chicago on April 28. The study showed how engineered cells derived from stem cells could transform the treatment of ovarian cancer. The data revealed that these engineered cells, which release powerful immune-boosting cytokines, not only shrink tumors but also help the body’s immune system to attack the cancer more effectively.Ernexa Therapeutics  is developing innovative cell therapies for the treatment of advanced solid tumors and autoimmune disease. Ernexa’s core technology focuses on engineering induced pluripotent stem cells  and transforming them into induce","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ernexa-therapeutics-presented-promising-data-123000498.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","BK4007","BK4139","ERNA"],"gpt_icon":0},{"id":"2529048903","title":"Ernexa Therapeutics Announces New Data to be Presented at AACR Annual Meeting 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2529048903","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529048903?lang=en_us&edition=fundamental","pubTime":"2025-04-22 20:30","pubTimestamp":1745325000,"startTime":"0","endTime":"0","summary":"Conference attendees will get first look at new data that supports the potential of ERNA-101 to boost anti-tumor immunity in ovarian cancer. CAMBRIDGE, Mass., April 22, 2025  -- Ernexa Therapeutics , developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced that new data will be presented at the American Association for Cancer Research  Annual Meeting 2025 in Chicago.The study explored the technology behind Ernexa’s lead cell therapy product, ERNA-101, which uses specially engineered cells to deliver treatment directly to ovarian tumors. By secreting immune-stimulating cytokines, this cell therapy treatment aims to reshape the tumor microenvironment and enhance anti-tumor immune responses, fighting off the cancer. The study was led by Michael Andreeff, M.D., Ph.D., from The University of Texas MD Anderson Cancer Center.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ernexa-therapeutics-announces-data-presented-123000673.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","LENZ","ERNA","BK4139"],"gpt_icon":0},{"id":"2524257934","title":"Ernexa Therapeutics Closes New Funding Round","url":"https://stock-news.laohu8.com/highlight/detail?id=2524257934","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524257934?lang=en_us&edition=fundamental","pubTime":"2025-04-03 20:55","pubTimestamp":1743684900,"startTime":"0","endTime":"0","summary":"Comes on the heels of company’s rebranding and new strategic direction, advancing its lead program in ovarian cancer. CAMBRIDGE, Mass., April 03, 2025  -- Ernexa Therapeutics , developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced that it has entered into a securities purchase agreement with accredited investors for the private placement of approximately 69.3 million shares of common stock , at a purchase price of $0.1046 per share for an aggregate purchase price of approximately $7,250,000, assuming the Company receives stockholder approval.“These are very exciting times at Ernexa, as we advance therapeutic innovation in cell therapy for the benefit of patients with cancer and autoimmune disease,” said Sanjeev Luther, President and CEO of Ernexa Therapeutics. “Our approach has been deliberate and strategic, from our investment round at the end of last year to our rebranding last month. With this latest round, we’re doubling d","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ernexa-therapeutics-closes-funding-round-125500118.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","ERNA","BK4139","PIPE"],"gpt_icon":0},{"id":"2506516429","title":"Eterna appoints Zeldis, Sather to scientific advisory board","url":"https://stock-news.laohu8.com/highlight/detail?id=2506516429","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506516429?lang=en_us&edition=fundamental","pubTime":"2025-01-28 21:46","pubTimestamp":1738071967,"startTime":"0","endTime":"0","summary":"Eterna (ERNA) Therapeutics announced the addition of Jerome Zeldis, M.D., Ph.D., and Blythe Sather, Ph.D., to the company’s scientific advisory boa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eterna-appoints-zeldis-sather-to-scientific-advisory-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eterna-appoints-zeldis-sather-to-scientific-advisory-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ERNA","BK4139"],"gpt_icon":0},{"id":"2506547515","title":"Eterna Therapeutics Announces Expansion of Scientific Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2506547515","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506547515?lang=en_us&edition=fundamental","pubTime":"2025-01-28 21:30","pubTimestamp":1738071001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250128:nTUAB5JDY6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ERNA","BK4139"],"gpt_icon":0},{"id":"2506651523","title":"Press Release: Eterna Therapeutics Announces Expansion of Scientific Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2506651523","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506651523?lang=en_us&edition=fundamental","pubTime":"2025-01-28 21:30","pubTimestamp":1738071000,"startTime":"0","endTime":"0","summary":"Dr. Jerome Zeldis and Dr. Blythe Sather bring exceptional backgrounds in cell therapy and solid tumors. CAMBRIDGE, Mass., Jan. 28, 2025  -- Eterna Therapeutics , a leader in cell therapies for the treatment of advanced solid tumors, today announced the addition of Jerome Zeldis, M.D., Ph.D., and Blythe Sather, Ph.D., to the company's scientific advisory board.\"We are fortunate to welcome Dr. Zeldis and Dr. Sather,\" said Sanjeev Luther, President & CEO of Eterna Therapeutics. \"Their extensive experience in developing transformative, high-profile cell therapies for solid tumors has been pivotal in advancing innovative treatments for patients. Their deep expertise will be invaluable as we continue to advance our cell therapies.\". Eterna Therapeutics is a publicly traded, preclinical-stage company focused on developing highly innovative, effective, safe off-the-shelf synthetic induced allogenic mesenchymal stem cell  therapies. Eterna's lead product ERNA-101 is an allogeneic pro-inflammato","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4565","BK4509","BK4007","ERNA","PROC","CAR","LU0359202008.SGD","LENZ","LU1023057109.AUD","BK4535","SG9999011746.SGD","BK4548","LU2039709279.SGD","BK4531","BK4552","BK4571","BK4563","IE00BYTNYN87.SGD","BK4139","LU0359201612.USD","BK4022","01698","BK4230","IE00BYQNZ168.SGD","BK4526","IE00B12V2V27.USD","TME","BK4108"],"gpt_icon":0},{"id":"2503571945","title":"Eterna Therapeutics Reports Positive Preclinical Results for Cancer Therapy ERNA-101; Shares Jump","url":"https://stock-news.laohu8.com/highlight/detail?id=2503571945","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503571945?lang=en_us&edition=fundamental","pubTime":"2025-01-14 22:46","pubTimestamp":1736866012,"startTime":"0","endTime":"0","summary":"Eterna Therapeutics'  shares nearly doubled in early trading on Tuesday after the company reported positive results from a preclinical study of its lead cell therapy product ERNA-101Eterna said the proof-of-concept study demonstrated \"massive\" T cell infiltration after only one dose, with reduced tumor burden and extended survival in mice with ovarian cancer.By changing the tumor microenvironment from having low immune activity to an active immune environment, ERNA-101 \"may not only lead to improved therapeutic outcomes as a monotherapy but is also anticipated to significantly enhance the efficacy of CAR-T and CAR-NK cell therapies in the future,\" the company said.Regarding safety, body weight distribution showed no significant difference between the ERNA-101 and control groups, Eterna said.Price: 0.4959, Change: +0.19, Percent Change: +60.49","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ERNA"],"gpt_icon":0},{"id":"2503360575","title":"Eterna announces preclinical study results on ERNA-101","url":"https://stock-news.laohu8.com/highlight/detail?id=2503360575","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503360575?lang=en_us&edition=fundamental","pubTime":"2025-01-14 21:45","pubTimestamp":1736862346,"startTime":"0","endTime":"0","summary":"Eterna (ERNA) Therapeutics announced positive results from a preclinical study on the company’s lead cell therapy product, ERNA-101, which is desig...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eterna-announces-preclinical-study-results-on-erna-101?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eterna-announces-preclinical-study-results-on-erna-101?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ERNA","BK4139"],"gpt_icon":0},{"id":"2503578460","title":"Eterna Therapeutics Inc - Erna-101 Expected to Enhance Efficacy of CAR-T and Car-Nk Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2503578460","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503578460?lang=en_us&edition=fundamental","pubTime":"2025-01-14 21:30","pubTimestamp":1736861401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250114:nTUA8BYHJM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ERNA","BK4139"],"gpt_icon":0},{"id":"2503578172","title":"Eterna Therapeutics Announces Positive Preclinical Study Results on Lead Product Erna-101 in Ovarian Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2503578172","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503578172?lang=en_us&edition=fundamental","pubTime":"2025-01-14 21:30","pubTimestamp":1736861401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250114:nTUA8BYHJM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ERNA"],"gpt_icon":0},{"id":"2503491578","title":"Eterna Therapeutics Inc - Erna-101 Treated Mice Show Significant Survival Advantage","url":"https://stock-news.laohu8.com/highlight/detail?id=2503491578","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503491578?lang=en_us&edition=fundamental","pubTime":"2025-01-14 21:30","pubTimestamp":1736861401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250114:nTUA8BYHJM:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ERNA","BK4139"],"gpt_icon":0},{"id":"2503957879","title":"Eterna Therapeutics Announces Positive Preclinical Study Results on Lead Product ERNA-101 in Ovarian Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2503957879","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503957879?lang=en_us&edition=fundamental","pubTime":"2025-01-14 21:30","pubTimestamp":1736861400,"startTime":"0","endTime":"0","summary":"New data from proof-of-concept study provides roadmap for treatment of ovarian cancerCAMBRIDGE, Mass., Jan.  14, 2025  (GLOBE NEWSWIRE) -- Eterna Therapeutics (Nasdaq: ERNA), a leader in cell therapie","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/14/3009318/0/en/Eterna-Therapeutics-Announces-Positive-Preclinical-Study-Results-on-Lead-Product-ERNA-101-in-Ovarian-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4571","BK4108","ERNA","IE00BYQNZ168.SGD","IE00BYTNYN87.SGD","01698","LU1023057109.AUD","BK4531","LU2039709279.SGD","LU0359202008.SGD","PROC","IE00B12V2V27.USD","BK4535","PBS","BK4007","BK4548","BK4565","BK4563","BK4509","SG9999011746.SGD","LU0359201612.USD","BK4526","BK4139","BK4552","TME"],"gpt_icon":0},{"id":"2502016465","title":"Eterna Therapeutics Announces Appointment of DR. Elena Ratner to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2502016465","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502016465?lang=en_us&edition=fundamental","pubTime":"2025-01-09 20:30","pubTimestamp":1736425800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250109:nTUA7GHQ9F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ERNA"],"gpt_icon":0},{"id":"2502016122","title":"Press Release: Eterna Therapeutics Announces Appointment of Dr. Elena Ratner to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2502016122","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502016122?lang=en_us&edition=fundamental","pubTime":"2025-01-09 20:30","pubTimestamp":1736425800,"startTime":"0","endTime":"0","summary":"World-renowned researcher brings expertise in obstetrics and gynecology from Yale University to advance Eterna's lead indication in ovarian cancer. CAMBRIDGE, Mass., Jan. 09, 2025  -- Eterna Therapeutics , a leader in cell therapies for the treatment of advanced solid tumors, today announced the appointment of Elena Ratner, M.D., M.B.A, to the Board of Directors.Dr. Ratner will spearhead the strategic direction of Eterna's efforts to combat ovarian cancer, leveraging her extensive expertise in obstetrics, gynecology, and reproductive sciences. Under her leadership, the company aims to accelerate advancements in innovative therapies targeting these high-priority areas in women's health. This direction is bolstered by Eterna's recent collaboration with MD Anderson Cancer Center. Announced last month, the partnership underscores Eterna's commitment to groundbreaking research in women's health, focusing on the development of novel approaches to improve outcomes for patients affected by ova","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4571","BK4108","ERNA","IE00BYQNZ168.SGD","IE00BYTNYN87.SGD","01698","LU1023057109.AUD","BK4531","LU2039709279.SGD","LU0359202008.SGD","LENZ","PROC","IE00B12V2V27.USD","BK4535","BK4007","BK4548","BK4565","BK4563","BK4509","SG9999011746.SGD","LU0359201612.USD","BK4526","BK4139","BK4552","TME"],"gpt_icon":0},{"id":"2500548121","title":"BRIEF-Eterna Therapeutics Inc - Receives Nasdaq Notice For Minimum Bid Price Non-Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2500548121","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500548121?lang=en_us&edition=fundamental","pubTime":"2025-01-04 05:22","pubTimestamp":1735939365,"startTime":"0","endTime":"0","summary":"Jan 3 (Reuters) - Eterna Therapeutics Inc   :   * ETERNA THERAPEUTICS INC - RECEIVES NASDAQ NOTICE FOR MINIMUM BID PRICE NON-COMPLIANCESource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","PSQ","TSYW.SI","LU2210150020.SGD","IE00BGHQF748.EUR","QID","LENZ","IE00BKPKM429.USD","QLD","USAW.SI","NQmain","ERNA","IE00B64PRP62.GBP","TQQQ","LU2095319765.USD","LU2210149790.SGD","MNQmain","NVIW.SI","IE00B3QW5Z07.USD","USJW.SI","NDAQ","SQQQ","BK4112",".IXIC","BK4588"],"gpt_icon":0},{"id":"2488910866","title":"Eterna launches research to evaluate ERNA-101","url":"https://stock-news.laohu8.com/highlight/detail?id=2488910866","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488910866?lang=en_us&edition=fundamental","pubTime":"2024-12-03 21:36","pubTimestamp":1733232973,"startTime":"0","endTime":"0","summary":"Eterna (ERNA) Therapeutics announced it will investigate the ability of its lead iMSC-based cell therapy, ERNA-101, to induce and modulate antitumo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eterna-launches-research-to-evaluate-erna-101?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eterna-launches-research-to-evaluate-erna-101?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ERNA"],"gpt_icon":0},{"id":"2488917983","title":"Eterna: to Investigate Ability of Erna-101 to Induce, Modulate Antitumor Immunity in Ovarian Cancer, Breast Cancer Models Through Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2488917983","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488917983?lang=en_us&edition=fundamental","pubTime":"2024-12-03 21:32","pubTimestamp":1733232761,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nFWN3N40KM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ERNA","BK4139"],"gpt_icon":0},{"id":"2488177369","title":"Eterna Therapeutics Launches Research to Evaluate its Lead Induced Mesenchymal Stem Cell Therapy Candidate’s (ERNA-101) Ability to Induce and Modulate Antitumor Immunity in Ovarian Cancer and Breast Cancer Models","url":"https://stock-news.laohu8.com/highlight/detail?id=2488177369","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488177369?lang=en_us&edition=fundamental","pubTime":"2024-12-03 21:30","pubTimestamp":1733232600,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Dec.  03, 2024  (GLOBE NEWSWIRE) -- Eterna Therapeutics(Nasdaq: ERNA) today announced it will investigate the ability of its lead iMSC-based cell therapy (ERNA-101) to induce and mod","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/03/2990647/0/en/Eterna-Therapeutics-Launches-Research-to-Evaluate-its-Lead-Induced-Mesenchymal-Stem-Cell-Therapy-Candidate-s-ERNA-101-Ability-to-Induce-and-Modulate-Antitumor-Immunity-in-Ovarian-C.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999011746.SGD","BK4531","ABIL","BK4571","TME","BK4548","IE00BYQNZ168.SGD","BK4139","BK4535","BK4552","ERNA","LU0359201612.USD","01698","LU1023057109.AUD","LU2039709279.SGD","BK4509","IE00BYTNYN87.SGD","IE00B12V2V27.USD","BK4526","LU0359202008.SGD","BK4108","BK4565","BK4563"],"gpt_icon":0},{"id":"2486408465","title":"BRIEF-Eterna Therapeutics Announces Up To $1 Million Stock Repurchase Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2486408465","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486408465?lang=en_us&edition=fundamental","pubTime":"2024-11-25 21:46","pubTimestamp":1732542365,"startTime":"0","endTime":"0","summary":"BRIEF-Eterna Therapeutics Announces Up To $1 Million Stock Repurchase ProgramNov 25 (Reuters) - Eterna Therapeutics Inc ERNA.O:ETERNA THERAPEUTICS ANNOUNCES UP TO $1 MILLION STOCK REPURCHASE PROGRAMSource text: ID:nGNX53S673Further company coverage: ERNA.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241125:nTUA3DPLPC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ERNA"],"gpt_icon":0},{"id":"2486084945","title":"Eterna Therapeutics announces up to $1 million stock repurchase program","url":"https://stock-news.laohu8.com/highlight/detail?id=2486084945","media":"seekingalpha","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486084945?lang=en_us&edition=fundamental","pubTime":"2024-11-25 21:42","pubTimestamp":1732542177,"startTime":"0","endTime":"0","summary":"Eterna Therapeutics (NASDAQ:ERNA) on Monday announced a stock repurchase program of up to $1 million of its outstanding common stock. ERNA  +9.61% premarket to  $0.57.\nSource: Press Release","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4329751-eterna-therapeutics-announces-up-to-1-million-stock-repurchase-program","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["NQmain",".IXIC","MNQmain","ERNA","TQQQ","LENZ","BK4139","SQQQ","QLD","QID","PSQ"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ERNA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-12","symbol":"ERNA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741752000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-12","symbol":"ERNA","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-4.92},{"market":"US","date":"2024-08-13","symbol":"ERNA","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-1.02},{"market":"US","date":"2024-05-14","symbol":"ERNA","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"post","actualEps":-1.23},{"market":"US","date":"2024-03-14","symbol":"ERNA","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1710388800000,"reportTimeType":"post","actualEps":-1.14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ERNA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ERNA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ERNA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ERNA","date":"2025-04-30","current":-0.243987,"percent":0.899396,"low":-414.27655,"twenty":-1.734033,"median":-0.540286,"eighty":-0.309592,"high":-0.075385,"avg":-6.767307,"sd":26.880947,"marketCap":10866945},"quantilePoints":[{"date":"2021-03-26","current":-25.050283,"twenty":-25.050283,"median":-25.050283,"eighty":-25.050283,"marketCap":197282700},{"date":"2021-04-01","current":-19.76073,"twenty":-22.50489,"median":-19.76073,"eighty":-19.686957,"marketCap":155625000},{"date":"2021-04-09","current":-33.883066,"twenty":-30.637037,"median":-24.82949,"eighty":-19.750191,"marketCap":266845000},{"date":"2021-04-16","current":-41.840053,"twenty":-33.50366,"median":-30.299787,"eighty":-21.44698,"marketCap":329510000},{"date":"2021-04-23","current":-85.155574,"twenty":-42.851802,"median":-31.986036,"eighty":-24.060665,"marketCap":670640000},{"date":"2021-04-30","current":-262.814932,"twenty":-85.482285,"median":-33.883066,"eighty":-24.961966,"marketCap":2069790588},{"date":"2021-05-07","current":-202.916348,"twenty":-203.739624,"median":-41.76101,"eighty":-26.678356,"marketCap":1598061207},{"date":"2021-05-14","current":-113.992019,"twenty":-184.841871,"median":-51.58868,"eighty":-29.656904,"marketCap":897740496},{"date":"2021-05-21","current":-23.451941,"twenty":-172.43288,"median":-41.76101,"eighty":-27.638585,"marketCap":581462452},{"date":"2021-05-28","current":-24.790712,"twenty":-163.283012,"median":-33.883066,"eighty":-24.914666,"marketCap":614655648},{"date":"2021-06-04","current":-27.975629,"twenty":-151.324405,"median":-33.408808,"eighty":-25.008431,"marketCap":693621825},{"date":"2021-06-11","current":-24.618554,"twenty":-136.546035,"median":-31.986036,"eighty":-25.008431,"marketCap":610387206},{"date":"2021-06-18","current":-27.459156,"twenty":-126.674306,"median":-31.4313,"eighty":-25.256072,"marketCap":680816499},{"date":"2021-06-25","current":-32.864909,"twenty":-117.855082,"median":-31.366149,"eighty":-25.558535,"marketCap":814845577},{"date":"2021-07-02","current":-30.0425,"twenty":-97.670284,"median":-31.300997,"eighty":-25.720363,"marketCap":744867381},{"date":"2021-07-09","current":-23.021892,"twenty":-86.135706,"median":-31.005605,"eighty":-25.503445,"marketCap":570799915},{"date":"2021-07-16","current":-17.907896,"twenty":-77.398829,"median":-30.178246,"eighty":-24.852689,"marketCap":444004578},{"date":"2021-07-23","current":-18.282091,"twenty":-60.093699,"median":-28.629829,"eighty":-23.901199,"marketCap":453282285},{"date":"2021-07-30","current":-20.473804,"twenty":-49.712728,"median":-28.247243,"eighty":-21.865619,"marketCap":507623144},{"date":"2021-08-06","current":-20.313434,"twenty":-44.875301,"median":-27.776888,"eighty":-21.432455,"marketCap":503646984},{"date":"2021-08-13","current":-17.513386,"twenty":-41.776819,"median":-27.272265,"eighty":-21.243576,"marketCap":575233152},{"date":"2021-08-20","current":-15.11947,"twenty":-41.218249,"median":-26.736094,"eighty":-20.908583,"marketCap":496604160},{"date":"2021-08-27","current":-18.033118,"twenty":-39.015872,"median":-26.305699,"eighty":-20.349072,"marketCap":592303920},{"date":"2021-09-03","current":-18.663096,"twenty":-36.032611,"median":-25.754795,"eighty":-19.707771,"marketCap":612995760},{"date":"2021-09-10","current":-19.308823,"twenty":-34.735027,"median":-25.393264,"eighty":-19.132429,"marketCap":634204896},{"date":"2021-09-17","current":-18.82059,"twenty":-33.788214,"median":-24.972717,"eighty":-19.025333,"marketCap":618168720},{"date":"2021-09-24","current":-14.930477,"twenty":-33.300028,"median":-24.618554,"eighty":-18.843094,"marketCap":490396608},{"date":"2021-10-01","current":-14.394995,"twenty":-32.77883,"median":-24.013514,"eighty":-18.637897,"marketCap":472808544},{"date":"2021-10-08","current":-13.103541,"twenty":-32.344818,"median":-22.959864,"eighty":-18.095512,"marketCap":430390272},{"date":"2021-10-15","current":-14.410745,"twenty":-31.986036,"median":-21.866106,"eighty":-17.513386,"marketCap":473325840},{"date":"2021-10-22","current":-14.190252,"twenty":-31.934562,"median":-21.542932,"eighty":-16.458173,"marketCap":466083696},{"date":"2021-10-29","current":-13.41853,"twenty":-31.706074,"median":-21.40929,"eighty":-15.371461,"marketCap":440736192},{"date":"2021-11-05","current":-14.914727,"twenty":-31.586644,"median":-21.186556,"eighty":-15.157269,"marketCap":489879312},{"date":"2021-11-12","current":-3.671231,"twenty":-31.462605,"median":-20.919274,"eighty":-14.943076,"marketCap":428840912},{"date":"2021-11-19","current":-3.038568,"twenty":-31.405239,"median":-20.812361,"eighty":-14.741483,"marketCap":354938716},{"date":"2021-11-26","current":-2.744513,"twenty":-31.300997,"median":-20.402528,"eighty":-14.53674,"marketCap":320589808},{"date":"2021-12-03","current":-2.30343,"twenty":-31.246626,"median":-20.10623,"eighty":-14.410745,"marketCap":269066446},{"date":"2021-12-10","current":-2.36135,"twenty":-31.005605,"median":-19.708035,"eighty":-14.269,"marketCap":275832140},{"date":"2021-12-17","current":-2.241055,"twenty":-30.381057,"median":-19.542356,"eighty":-14.143004,"marketCap":261780314},{"date":"2021-12-23","current":-2.223233,"twenty":-30.316041,"median":-19.293073,"eighty":-13.742968,"marketCap":259698562},{"date":"2021-12-31","current":-1.857892,"twenty":-30.105321,"median":-19.009584,"eighty":-13.387031,"marketCap":217022646},{"date":"2022-01-07","current":-1.71532,"twenty":-30.045341,"median":-18.896839,"eighty":-13.031093,"marketCap":200368630},{"date":"2022-01-14","current":-1.434632,"twenty":-28.912363,"median":-18.82059,"eighty":-3.425295,"marketCap":167581036},{"date":"2022-01-21","current":-1.189586,"twenty":-28.520385,"median":-18.663096,"eighty":-2.991341,"marketCap":138956946},{"date":"2022-01-28","current":-1.127211,"twenty":-28.335341,"median":-18.328147,"eighty":-2.757879,"marketCap":131670814},{"date":"2022-02-04","current":-1.069291,"twenty":-28.244568,"median":-18.048867,"eighty":-2.58501,"marketCap":124905120},{"date":"2022-02-11","current":-1.015826,"twenty":-28.078924,"median":-17.710641,"eighty":-2.393429,"marketCap":118659864},{"date":"2022-02-18","current":-0.984638,"twenty":-27.856384,"median":-17.11965,"eighty":-2.241055,"marketCap":115016798},{"date":"2022-02-25","current":-0.993549,"twenty":-27.75309,"median":-16.710164,"eighty":-2.200065,"marketCap":116057674},{"date":"2022-03-04","current":-0.850977,"twenty":-27.614098,"median":-15.749448,"eighty":-2.151056,"marketCap":99403658},{"date":"2022-03-11","current":-0.85837,"twenty":-27.309643,"median":-15.418709,"eighty":-1.947891,"marketCap":100267205},{"date":"2022-03-18","current":-0.907292,"twenty":-26.980094,"median":-15.253341,"eighty":-1.74829,"marketCap":105981916},{"date":"2022-03-25","current":-0.92953,"twenty":-26.787741,"median":-15.11947,"eighty":-1.632451,"marketCap":108579512},{"date":"2022-04-01","current":-0.889502,"twenty":-26.66879,"median":-14.961976,"eighty":-1.329484,"marketCap":103903840},{"date":"2022-04-08","current":-0.778315,"twenty":-26.504298,"median":-14.772982,"eighty":-1.217209,"marketCap":90915860},{"date":"2022-04-14","current":-0.729392,"twenty":-26.367676,"median":-14.741483,"eighty":-1.191368,"marketCap":85201148},{"date":"2022-04-22","current":-0.581341,"twenty":-26.136985,"median":-14.583989,"eighty":-1.092459,"marketCap":71240380},{"date":"2022-04-29","current":-0.492264,"twenty":-25.851203,"median":-14.489492,"eighty":-1.070182,"marketCap":60324516},{"date":"2022-05-06","current":-0.435255,"twenty":-25.737579,"median":-14.40287,"eighty":-1.023845,"marketCap":53338362},{"date":"2022-05-13","current":-0.374027,"twenty":-25.613626,"median":-14.363496,"eighty":-1.003351,"marketCap":45835141},{"date":"2022-05-20","current":-0.336474,"twenty":-25.324668,"median":-14.190252,"eighty":-0.973054,"marketCap":41233242},{"date":"2022-05-27","current":-0.315424,"twenty":-25.040182,"median":-14.143004,"eighty":-0.944652,"marketCap":38653651},{"date":"2022-06-03","current":-0.285326,"twenty":-24.999779,"median":-13.954011,"eighty":-0.925082,"marketCap":34965238},{"date":"2022-06-10","current":-0.295218,"twenty":-24.945654,"median":-13.631147,"eighty":-0.907292,"marketCap":36177474},{"date":"2022-06-17","current":-0.229723,"twenty":-24.790712,"median":-13.387031,"eighty":-0.898397,"marketCap":28151440},{"date":"2022-06-24","current":-0.269573,"twenty":-24.652986,"median":-13.371281,"eighty":-0.866375,"marketCap":33034854},{"date":"2022-07-01","current":-0.27255,"twenty":-24.610668,"median":-12.922422,"eighty":-0.837611,"marketCap":30906602},{"date":"2022-07-08","current":-0.361389,"twenty":-24.58853,"median":-3.657865,"eighty":-0.813005,"marketCap":40980844},{"date":"2022-07-15","current":-0.294291,"twenty":-23.901199,"median":-3.368266,"eighty":-0.76942,"marketCap":33372004},{"date":"2022-07-22","current":-0.270675,"twenty":-23.193912,"median":-2.989559,"eighty":-0.706884,"marketCap":30693968},{"date":"2022-07-29","current":-0.247008,"twenty":-22.984675,"median":-2.922728,"eighty":-0.592592,"marketCap":28010185},{"date":"2022-08-05","current":-0.267786,"twenty":-22.74049,"median":-2.697731,"eighty":-0.525082,"marketCap":30366397},{"date":"2022-08-12","current":-0.314274,"twenty":-22.158822,"median":-2.615307,"eighty":-0.485701,"marketCap":33536542},{"date":"2022-08-19","current":-0.260857,"twenty":-21.865619,"median":-2.45714,"eighty":-0.412611,"marketCap":27836330},{"date":"2022-08-26","current":-0.220505,"twenty":-21.788831,"median":-2.36135,"eighty":-0.368972,"marketCap":23530288},{"date":"2022-09-02","current":-0.209424,"twenty":-21.621334,"median":-2.247738,"eighty":-0.348362,"marketCap":22347891},{"date":"2022-09-09","current":-0.190516,"twenty":-21.507294,"median":-2.232144,"eighty":-0.335714,"marketCap":20330168},{"date":"2022-09-16","current":-0.17238,"twenty":-21.439583,"median":-2.18759,"eighty":-0.325246,"marketCap":18394802},{"date":"2022-09-23","current":-0.126956,"twenty":-21.411072,"median":-2.163086,"eighty":-0.314749,"marketCap":13547563},{"date":"2022-09-30","current":-0.136107,"twenty":-21.371871,"median":-2.143037,"eighty":-0.307812,"marketCap":14524070},{"date":"2022-10-07","current":-0.127397,"twenty":-21.272086,"median":-1.958139,"eighty":-0.305326,"marketCap":13594623},{"date":"2022-10-14","current":-0.113064,"twenty":-21.165173,"median":-1.857892,"eighty":-0.296303,"marketCap":12065155},{"date":"2022-10-21","current":-0.100605,"twenty":-21.047569,"median":-1.717548,"eighty":-0.292372,"marketCap":10735693},{"date":"2022-10-28","current":-0.097022,"twenty":-20.919274,"median":-1.661856,"eighty":-0.287257,"marketCap":10353326},{"date":"2022-11-04","current":-0.080484,"twenty":-20.912146,"median":-1.470275,"eighty":-0.277075,"marketCap":8588555},{"date":"2022-11-11","current":-0.089304,"twenty":-20.865817,"median":-1.30097,"eighty":-0.268501,"marketCap":9529766},{"date":"2022-11-18","current":-0.334689,"twenty":-20.676938,"median":-1.229684,"eighty":-0.270014,"marketCap":9385362},{"date":"2022-11-25","current":-0.346231,"twenty":-20.459549,"median":-1.211863,"eighty":-0.27105,"marketCap":9708996},{"date":"2022-12-02","current":-0.346231,"twenty":-20.384709,"median":-1.189586,"eighty":-0.27293,"marketCap":9708996},{"date":"2022-12-09","current":-1.003766,"twenty":-20.299179,"median":-1.104934,"eighty":-0.275762,"marketCap":28147614},{"date":"2022-12-16","current":-0.687461,"twenty":-20.187787,"median":-1.087112,"eighty":-0.281392,"marketCap":19277783},{"date":"2022-12-23","current":-0.627125,"twenty":-19.928386,"median":-1.071519,"eighty":-0.283392,"marketCap":17585850},{"date":"2022-12-30","current":-0.58873,"twenty":-19.76073,"median":-1.058152,"eighty":-0.285326,"marketCap":16509165},{"date":"2023-01-06","current":-0.62164,"twenty":-19.718574,"median":-1.029192,"eighty":-0.286526,"marketCap":17432038},{"date":"2023-01-13","current":-0.850185,"twenty":-19.707683,"median":-1.011371,"eighty":-0.287688,"marketCap":23840875},{"date":"2023-01-20","current":-0.895893,"twenty":-19.644625,"median":-1.003766,"eighty":-0.287904,"marketCap":25122643},{"date":"2023-01-27","current":-0.884923,"twenty":-19.530298,"median":-0.989094,"eighty":-0.289577,"marketCap":24815018},{"date":"2023-02-03","current":-0.870296,"twenty":-19.378121,"median":-0.971272,"eighty":-0.290932,"marketCap":24404853},{"date":"2023-02-10","current":-0.745054,"twenty":-19.289924,"median":-0.957065,"eighty":-0.293011,"marketCap":20892810},{"date":"2023-02-17","current":-0.694793,"twenty":-19.163928,"median":-0.92953,"eighty":-0.294847,"marketCap":19483378},{"date":"2023-02-24","current":-0.667349,"twenty":-19.056832,"median":-0.925082,"eighty":-0.295274,"marketCap":18713805},{"date":"2023-03-03","current":-0.674663,"twenty":-18.996984,"median":-0.917925,"eighty":-0.295584,"marketCap":18918888},{"date":"2023-03-10","current":-0.642538,"twenty":-18.956278,"median":-0.91174,"eighty":-0.296303,"marketCap":18018062},{"date":"2023-03-17","current":-0.638095,"twenty":-18.902185,"median":-0.908794,"eighty":-0.297808,"marketCap":17893474},{"date":"2023-03-24","current":-0.688365,"twenty":-18.856603,"median":-0.907778,"eighty":-0.300802,"marketCap":16919331},{"date":"2023-03-31","current":-0.709225,"twenty":-18.83004,"median":-0.905069,"eighty":-0.30391,"marketCap":17432038},{"date":"2023-04-06","current":-0.705053,"twenty":-18.792241,"median":-0.899191,"eighty":-0.305155,"marketCap":17329496},{"date":"2023-04-14","current":-0.682107,"twenty":-18.675695,"median":-0.895893,"eighty":-0.305841,"marketCap":16765518},{"date":"2023-04-21","current":-0.670748,"twenty":-18.656796,"median":-0.888836,"eighty":-0.305955,"marketCap":16486310},{"date":"2023-04-28","current":-0.615289,"twenty":-18.579515,"median":-0.884923,"eighty":-0.306454,"marketCap":15123199},{"date":"2023-05-05","current":-0.681327,"twenty":-18.35397,"median":-0.875781,"eighty":-0.30726,"marketCap":16746347},{"date":"2023-05-12","current":-0.599864,"twenty":-18.284505,"median":-0.868468,"eighty":-0.310367,"marketCap":14744066},{"date":"2023-05-19","current":-0.69109,"twenty":-18.235446,"median":-0.861071,"eighty":-0.314018,"marketCap":14250274},{"date":"2023-05-26","current":-0.488159,"twenty":-18.045717,"median":-0.853841,"eighty":-0.314279,"marketCap":10065837},{"date":"2023-06-02","current":-0.55461,"twenty":-18.033118,"median":-0.850185,"eighty":-0.314299,"marketCap":11436056},{"date":"2023-06-09","current":-0.527518,"twenty":-17.907896,"median":-0.837611,"eighty":-0.315424,"marketCap":10877428},{"date":"2023-06-16","current":-0.569945,"twenty":-17.513386,"median":-0.832175,"eighty":-0.317417,"marketCap":11752260},{"date":"2023-06-23","current":-0.644063,"twenty":-17.513386,"median":-0.831793,"eighty":-0.320326,"marketCap":13280581},{"date":"2023-06-30","current":-0.572526,"twenty":-17.355892,"median":-0.82774,"eighty":-0.322914,"marketCap":11805488},{"date":"2023-07-07","current":-0.590391,"twenty":-17.066102,"median":-0.803551,"eighty":-0.324567,"marketCap":12173866},{"date":"2023-07-14","current":-0.66704,"twenty":-16.82356,"median":-0.782762,"eighty":-0.327297,"marketCap":13754360},{"date":"2023-07-21","current":-0.744904,"twenty":-16.647166,"median":-0.776828,"eighty":-0.327511,"marketCap":15359929},{"date":"2023-07-28","current":-0.711057,"twenty":-16.278629,"median":-0.757656,"eighty":-0.328261,"marketCap":14661997},{"date":"2023-08-04","current":-0.750414,"twenty":-15.787247,"median":-0.753246,"eighty":-0.329188,"marketCap":15473546},{"date":"2023-08-11","current":-0.703186,"twenty":-15.661251,"median":-0.750388,"eighty":-0.332171,"marketCap":14499687},{"date":"2023-08-18","current":-0.600041,"twenty":-15.532105,"median":-0.744379,"eighty":-0.334793,"marketCap":13038897},{"date":"2023-08-25","current":-0.560205,"twenty":-15.39981,"median":-0.742386,"eighty":-0.335461,"marketCap":12173244},{"date":"2023-09-01","current":-0.607511,"twenty":-15.324213,"median":-0.734672,"eighty":-0.336537,"marketCap":13201207},{"date":"2023-09-08","current":-0.580123,"twenty":-15.324213,"median":-0.729424,"eighty":-0.336725,"marketCap":12606071},{"date":"2023-09-15","current":-0.522858,"twenty":-15.239166,"median":-0.7268,"eighty":-0.337894,"marketCap":11361695},{"date":"2023-09-21","current":-0.512898,"twenty":-15.176168,"median":-0.724917,"eighty":-0.339521,"marketCap":11145281},{"date":"2023-09-29","current":-0.562694,"twenty":-15.144669,"median":-0.721172,"eighty":-0.343293,"marketCap":12227348},{"date":"2023-10-06","current":-0.525347,"twenty":-15.103721,"median":-0.714743,"eighty":-0.344552,"marketCap":11415798},{"date":"2023-10-13","current":-0.502939,"twenty":-15.031273,"median":-0.713021,"eighty":-0.346231,"marketCap":10928868},{"date":"2023-10-19","current":-0.49796,"twenty":-15.002924,"median":-0.710141,"eighty":-0.346231,"marketCap":10820662},{"date":"2023-10-23","current":-0.43696,"twenty":-14.993474,"median":-0.709225,"eighty":-0.346231,"marketCap":9495130},{"date":"2023-11-01","current":-0.351037,"twenty":-14.955676,"median":-0.709225,"eighty":-0.345391,"marketCap":7628025},{"date":"2023-11-10","current":-0.273878,"twenty":-14.921027,"median":-0.709037,"eighty":-0.340114,"marketCap":5951364},{"date":"2023-11-17","current":-0.31245,"twenty":-14.82968,"median":-0.707356,"eighty":-0.335,"marketCap":6250555},{"date":"2023-11-24","current":-0.265215,"twenty":-14.760382,"median":-0.706616,"eighty":-0.328346,"marketCap":5305370},{"date":"2023-12-01","current":-0.243416,"twenty":-14.741483,"median":-0.705095,"eighty":-0.324798,"marketCap":4869303},{"date":"2023-12-08","current":-0.392171,"twenty":-14.703684,"median":-0.703916,"eighty":-0.324798,"marketCap":7844979},{"date":"2023-12-15","current":-0.489537,"twenty":-14.640686,"median":-0.702088,"eighty":-0.326602,"marketCap":9792699},{"date":"2023-12-22","current":-0.462491,"twenty":-14.593438,"median":-0.69638,"eighty":-0.32727,"marketCap":9251666},{"date":"2023-12-29","current":-0.497624,"twenty":-14.53674,"median":-0.694793,"eighty":-0.327285,"marketCap":9954468},{"date":"2024-01-05","current":-0.530106,"twenty":-14.508391,"median":-0.69077,"eighty":-0.327321,"marketCap":10604248},{"date":"2024-01-12","current":-0.473309,"twenty":-14.489492,"median":-0.689289,"eighty":-0.327844,"marketCap":9468079},{"date":"2024-01-19","current":-0.375943,"twenty":-14.464293,"median":-0.687461,"eighty":-0.328346,"marketCap":7520360},{"date":"2024-01-26","current":-0.476041,"twenty":-14.420194,"median":-0.685956,"eighty":-0.329362,"marketCap":9522723},{"date":"2024-02-02","current":-0.462491,"twenty":-14.404445,"median":-0.684214,"eighty":-0.33092,"marketCap":9251666},{"date":"2024-02-09","current":-0.43274,"twenty":-14.394995,"median":-0.681717,"eighty":-0.332801,"marketCap":8656529},{"date":"2024-02-16","current":-0.430035,"twenty":-14.382395,"median":-0.679793,"eighty":-0.334897,"marketCap":8602426},{"date":"2024-02-23","current":-0.411103,"twenty":-14.344597,"median":-0.675577,"eighty":-0.335461,"marketCap":8223703},{"date":"2024-03-01","current":-0.421921,"twenty":-14.25325,"median":-0.673579,"eighty":-0.336537,"marketCap":8440116},{"date":"2024-03-08","current":-0.538193,"twenty":-14.190252,"median":-0.670748,"eighty":-0.337157,"marketCap":10766017},{"date":"2024-03-15","current":-0.593665,"twenty":-14.183952,"median":-0.669178,"eighty":-0.339125,"marketCap":11875676},{"date":"2024-03-22","current":-0.581708,"twenty":-14.155604,"median":-0.667349,"eighty":-0.341102,"marketCap":12604448},{"date":"2024-03-28","current":-0.559311,"twenty":-14.143004,"median":-0.66704,"eighty":-0.341102,"marketCap":12119141},{"date":"2024-04-05","current":-0.574292,"twenty":-14.095756,"median":-0.664588,"eighty":-0.343083,"marketCap":12443761},{"date":"2024-04-12","current":-0.564304,"twenty":-13.954011,"median":-0.659122,"eighty":-0.344132,"marketCap":12227348},{"date":"2024-04-19","current":-0.536838,"twenty":-13.765017,"median":-0.655936,"eighty":-0.346231,"marketCap":11632211},{"date":"2024-04-26","current":-0.433391,"twenty":-13.654771,"median":-0.651731,"eighty":-0.346231,"marketCap":9390711},{"date":"2024-05-03","current":-0.426974,"twenty":-13.607523,"median":-0.643822,"eighty":-0.346642,"marketCap":9251666},{"date":"2024-05-10","current":-0.539335,"twenty":-13.41853,"median":-0.641752,"eighty":-0.349508,"marketCap":11686314},{"date":"2024-05-17","current":-0.479627,"twenty":-13.387031,"median":-0.635906,"eighty":-0.351037,"marketCap":10982971},{"date":"2024-05-24","current":-0.470176,"twenty":-13.387031,"median":-0.634777,"eighty":-0.351664,"marketCap":10766558},{"date":"2024-05-31","current":-0.432373,"twenty":-13.374431,"median":-0.63384,"eighty":-0.351664,"marketCap":9900905},{"date":"2024-06-07","current":-0.481989,"twenty":-13.220087,"median":-0.632737,"eighty":-0.352354,"marketCap":11037075},{"date":"2024-06-14","current":-0.467813,"twenty":-13.13504,"median":-0.628835,"eighty":-0.352526,"marketCap":10712455},{"date":"2024-06-21","current":-0.464624,"twenty":-12.958646,"median":-0.624821,"eighty":-0.35433,"marketCap":10639415},{"date":"2024-06-28","current":-0.413471,"twenty":-12.813751,"median":-0.623177,"eighty":-0.356135,"marketCap":9468079},{"date":"2024-07-05","current":-0.415834,"twenty":-7.29926,"median":-0.621325,"eighty":-0.358737,"marketCap":9522182},{"date":"2024-07-12","current":-0.458362,"twenty":-3.655192,"median":-0.61996,"eighty":-0.360781,"marketCap":10496042},{"date":"2024-07-15","current":-0.484352,"twenty":-3.649845,"median":-0.617625,"eighty":-0.361085,"marketCap":11091178},{"date":"2024-08-02","current":-0.406407,"twenty":-3.644499,"median":-0.615289,"eighty":-0.361389,"marketCap":9306310},{"date":"2024-08-09","current":-0.434759,"twenty":-3.439552,"median":-0.612499,"eighty":-0.367214,"marketCap":9955550},{"date":"2024-08-16","current":-0.391318,"twenty":-3.368266,"median":-0.609386,"eighty":-0.373509,"marketCap":9360317},{"date":"2024-08-23","current":-0.420723,"twenty":-3.038568,"median":-0.605511,"eighty":-0.374027,"marketCap":10063693},{"date":"2024-08-30","current":-0.413937,"twenty":-2.998469,"median":-0.605021,"eighty":-0.37459,"marketCap":9901376},{"date":"2024-09-06","current":-0.380008,"twenty":-2.984212,"median":-0.602531,"eighty":-0.375672,"marketCap":9089787},{"date":"2024-09-13","current":-0.346079,"twenty":-2.962826,"median":-0.599952,"eighty":-0.366049,"marketCap":8278199},{"date":"2024-09-20","current":-0.285006,"twenty":-2.929857,"median":-0.598858,"eighty":-0.352526,"marketCap":6817340},{"date":"2024-09-27","current":-0.287268,"twenty":-2.797978,"median":-0.594949,"eighty":-0.35095,"marketCap":6871446},{"date":"2024-10-04","current":-0.214863,"twenty":-2.748968,"median":-0.593665,"eighty":-0.348935,"marketCap":5139517},{"date":"2024-10-11","current":-0.242029,"twenty":-2.669663,"median":-0.591669,"eighty":-0.34569,"marketCap":5789329},{"date":"2024-10-18","current":-0.242029,"twenty":-2.647385,"median":-0.587835,"eighty":-0.341464,"marketCap":5789329},{"date":"2024-10-25","current":-0.214908,"twenty":-2.621544,"median":-0.585317,"eighty":-0.338262,"marketCap":5140599},{"date":"2024-10-31","current":-0.248815,"twenty":-2.569862,"median":-0.582161,"eighty":-0.335,"marketCap":5951646},{"date":"2024-11-08","current":-0.244291,"twenty":-2.496793,"median":-0.581341,"eighty":-0.32843,"marketCap":5843435},{"date":"2024-11-15","current":-1.08538,"twenty":-2.454913,"median":-0.581379,"eighty":-0.327844,"marketCap":48769398},{"date":"2024-11-22","current":-0.608498,"twenty":-2.42729,"median":-0.582613,"eighty":-0.32843,"marketCap":27341622},{"date":"2024-11-29","current":-0.485929,"twenty":-2.393429,"median":-0.582613,"eighty":-0.329362,"marketCap":21834253},{"date":"2024-12-06","current":-0.362332,"twenty":-2.344648,"median":-0.581379,"eighty":-0.33092,"marketCap":16280646},{"date":"2024-12-13","current":-0.331346,"twenty":-2.313128,"median":-0.577612,"eighty":-0.331424,"marketCap":14888391},{"date":"2024-12-20","current":-0.282982,"twenty":-2.283826,"median":-0.574292,"eighty":-0.328346,"marketCap":12715241},{"date":"2024-12-27","current":-0.323686,"twenty":-2.251748,"median":-0.574198,"eighty":-0.327265,"marketCap":14544181},{"date":"2025-01-03","current":-0.421901,"twenty":-2.241055,"median":-0.57259,"eighty":-0.326164,"marketCap":18957269},{"date":"2025-01-10","current":-0.369649,"twenty":-2.241055,"median":-0.571345,"eighty":-0.327041,"marketCap":16609444},{"date":"2025-01-17","current":-0.51337,"twenty":-2.226797,"median":-0.569945,"eighty":-0.32728,"marketCap":23067246},{"date":"2025-01-24","current":-0.66315,"twenty":-2.22056,"median":-0.569945,"eighty":-0.327321,"marketCap":29797333},{"date":"2025-01-31","current":-0.418928,"twenty":-2.200065,"median":-0.568486,"eighty":-0.327844,"marketCap":18823694},{"date":"2025-02-07","current":-0.388743,"twenty":-2.176897,"median":-0.56679,"eighty":-0.32843,"marketCap":17467402},{"date":"2025-02-14","current":-0.32906,"twenty":-2.169769,"median":-0.565812,"eighty":-0.327844,"marketCap":14785642},{"date":"2025-02-21","current":-0.387486,"twenty":-2.164423,"median":-0.564304,"eighty":-0.328346,"marketCap":17410890},{"date":"2025-02-28","current":-0.326773,"twenty":-2.152839,"median":-0.562694,"eighty":-0.328346,"marketCap":14682892},{"date":"2025-03-07","current":-0.33672,"twenty":-2.14571,"median":-0.559758,"eighty":-0.327309,"marketCap":15129852},{"date":"2025-03-14","current":-0.294137,"twenty":-2.093137,"median":-0.557899,"eighty":-0.32643,"marketCap":13100551},{"date":"2025-03-21","current":-0.317418,"twenty":-2.014722,"median":-0.555167,"eighty":-0.324255,"marketCap":14137477},{"date":"2025-03-28","current":-0.265453,"twenty":-1.968386,"median":-0.554317,"eighty":-0.319136,"marketCap":11823027},{"date":"2025-04-04","current":-0.212316,"twenty":-1.894427,"median":-0.551298,"eighty":-0.318025,"marketCap":9456332},{"date":"2025-04-11","current":-0.218415,"twenty":-1.868585,"median":-0.549323,"eighty":-0.314749,"marketCap":9728005},{"date":"2025-04-17","current":-0.2156,"twenty":-1.844526,"median":-0.544579,"eighty":-0.312751,"marketCap":9602617},{"date":"2025-04-25","current":-0.240351,"twenty":-1.776805,"median":-0.542304,"eighty":-0.310623,"marketCap":10704985},{"date":"2025-04-30","current":-0.243987,"twenty":-1.734033,"median":-0.540286,"eighty":-0.309592,"marketCap":10866945}],"updateTime":1746138316975}}}